Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: In Obesity, Vivus Raises Cash For Deals, Orexigen Finds A Buyer

May 03 2018

• By Mandy Jackson

Finance Watch

Related Content

Rubraca Ovarian Cancer Maintenance Approval Brings PARP Inhibitor Parity On Broad Indication

Apr 08 2018

Arena Rises With Post-Belviq Pipeline

Jan 30 2018

Deal Watch: Inventiva Expands Collaborations With Boehringer, AbbVie

Sep 05 2017

Rising Tide Lifts All CAR-T Ships After Gilead/Kite Deal, Kymriah Approval

Sep 04 2017

Paratek Sees Broad Potential For Omadacycline After Second Phase III Win

Apr 04 2017

Orexigen Begins Slow Climb Up Slippery Slope Of Obesity Drug Sales

Oct 14 2016

Arena Rises, But Raises Questions With Phase II Ralinepag Data In PAH

Jul 11 2017

RSV Market: An Unmet Clinical Need For ReViral, And Big Pharma Too

Feb 08 2018

Gilead Partners With Sangamo For Gene Editing As It Builds Up Kite's Cell Therapy Platform

Feb 23 2018

Pipeline Watch: Phase III Updates For Eravacycline, Opdivo And Keytruda

Apr 20 2018

Rigel Readies Tavalisse For Late-May Launch After FDA Approval

Apr 18 2018

New Mechanism And Oral Activity Underline Selinexor's Role In Multiple Myeloma

May 01 2018

Orexigen Follows Through On Warning It May Have To Liquidate

Mar 13 2018

Arena Ready For Etrasimod Phase III Face-Off With Celgene's Ozanimod In UC

Mar 20 2018

Apellis Eyes Progress For Lead AMD Product

Aug 25 2017

Deal Watch: Array Partners With Ono On Cancer Drugs In Japan, South Korea

Jun 02 2017

If Orexigen Disappears, Who's Left In The Obesity Market?

Oct 18 2017

Related Companies

Vivus, Inc.

Arena Pharmaceuticals, Inc.

Orexigen Therapeutics, Inc.

Johnson & Johnson

Johnson & Johnson

Selten Pharma LLC

Takeda Pharmaceutical Co. Ltd.

Currax Pharmaceuticals LLC

Eisai Co., Ltd.

Clovis Oncology, Inc.

Sangamo Therapeutics, Inc.

Gilead Sciences, Inc.

Karyopharm Therapeutics

Apellis Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc.

Sevion Therapeutics, Inc.

Novavax, Inc.

Inventiva S.A.

Boehringer Ingelheim GmbH

AbbVie Inc.

Spyre Therapeutics, Inc.

BerGenBio ASA

Nymox Pharmaceutical Corporation

Kiora Pharmaceuticals, Inc.

Cystic Fibrosis Foundation

Icagen, Inc.

Entero Therapeutics, Inc.

Astria Therapeutics, Inc.

Celldex Therapeutics, Inc.

Eloxx Pharmaceuticals, Inc.

Additional Topics

Financing Business Strategies Strategy Commercial Metabolic Disorders BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window